Target Name: CNP
NCBI ID: G1267
Review Report on CNP Target / Biomarker Content of Review Report on CNP Target / Biomarker
CNP
Other Name(s): CN37_HUMAN | CNP1 | CNPase | 2',3'-cyclic-nucleotide 3'-phosphodiesterase | CNP variant 1 | HLD20 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase (isoform 1) | 2',3'-cyclic nucleotide 3' phosphodiester

A promising drug target: CNP (CN37_HUMAN), a potential therapeutic target for cancer and neurodegenerative diseases

Abstract:

CNP (Cannabinol Phosphate) is a natural compound found in various plants and animals, including the cannabis plant. Research has shown that CNP has potential as a drug target due to its unique biological activity. This article reviews the pharmacological effects, mechanism of action and pharmacodynamic properties of CNP, and explores the application prospects of CNP in the treatment of cancer and neurodegenerative diseases.

1 Introduction

CNP, as a bioactive small molecule, is widely distributed in plants and animals. In recent years, with the rapid development of bioinformatics, people have found that CNP has a variety of biological activities, such as antioxidant, anti-inflammatory, anti-cancer, immune regulation, etc. These biological activities make CNPs a research area of 鈥嬧?媑reat interest. This article aims to systematically summarize the pharmacological effects, mechanism of action and pharmacodynamic properties of CNP, and provide certain theoretical support for the application prospects of CNP in the treatment of cancer and neurodegenerative diseases.

2. Pharmacological effects of CNP

2.1 Antioxidant effect

CNP has a strong antioxidant effect and can scavenge free radicals in cells and inhibit oxidative stress. Many studies have shown that CNP can significantly reduce the level of oxidative stress in cells, thus protecting cells from damage caused by oxidative stress to a certain extent.

2.2 Anti-inflammatory effect

CNP has anti-inflammatory effects and can alleviate inflammatory reactions. In inflammatory diseases, the role of CNP is particularly important. Studies have found that CNP can significantly reduce the inflammatory response, thus having a certain therapeutic effect on inflammatory diseases.

2.3 Anti-cancer effect

CNP has anti-cancer effects and can inhibit the growth and metastasis of cancer cells. CNP exerts its anti-cancer effect mainly by inhibiting the signaling pathways of cancer cell growth factors. In addition, CNP can also regulate the metabolism of cancer cells, thereby inhibiting the growth of cancer cells.

2.4 Regulate immune function

CNP has significant immunomodulatory effects and can enhance the body's immunity. CNP regulates cytokines and T cell activity

Protein Name: 2',3'-cyclic Nucleotide 3' Phosphodiesterase

Functions: Catalyzes the formation of 2'-nucleotide products from 2',3'-cyclic substrates (By similarity). May participate in RNA metabolism in the myelinating cell, CNP is the third most abundant protein in central nervous system myelin (By similarity)

The "CNP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CNP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CNPPD1 | CNPY1 | CNPY2 | CNPY3 | CNPY4 | CNR1 | CNR2 | CNRIP1 | CNST | CNTD1 | CNTF | CNTFR | CNTLN | CNTN1 | CNTN2 | CNTN3 | CNTN4 | CNTN4-AS1 | CNTN4-AS2 | CNTN5 | CNTN6 | CNTNAP1 | CNTNAP2 | CNTNAP2-AS1 | CNTNAP3 | CNTNAP3B | CNTNAP3P2 | CNTNAP4 | CNTNAP5 | CNTRL | CNTROB | COA1 | COA3 | COA4 | COA5 | COA6 | COA6-AS1 | COA7 | COA8 | Coagulation Factor XIII | COASY | Coatomer protein complex | COBL | COBLL1 | COCH | COG1 | COG2 | COG3 | COG4 | COG5 | COG6 | COG7 | COG8 | Cohesin complex | Cohesin loading complex | COIL | COL10A1 | COL11A1 | COL11A2 | COL11A2P1 | COL12A1 | COL13A1 | COL14A1 | COL15A1 | COL16A1 | COL17A1 | COL18A1 | COL18A1-AS1 | COL19A1 | COL1A1 | COL1A2 | COL1A2-AS1 | COL20A1 | COL21A1 | COL22A1 | COL23A1 | COL24A1 | COL25A1 | COL26A1 | COL27A1 | COL28A1 | COL2A1 | COL3A1 | COL4A1 | COL4A2 | COL4A2-AS1 | COL4A3 | COL4A4 | COL4A5 | COL4A6 | COL5A1 | COL5A2 | COL5A3 | COL6A1 | COL6A2 | COL6A3 | COL6A4P1 | COL6A4P2 | COL6A5 | COL6A6